Marshall Wace, LLP Heska Corp Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$60.21 - $77.74 $862,869 - $1.11 Million	-14,331 Reduced 45.66%	17,056 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$72.92 - $99.73 $2.29 Million - $3.13 Million	31,387 New	31,387 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$84.23 - $147.57 $246,625 - $432,084	-2,928 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$122.89 - $171.74 $124,487 - $173,972	1,013 Added 52.9%	2,928 $405,000
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $298,740 - $508,968	1,915 New	1,915 $350,000
Q2 2021 Aug 13, 2021	SELL	$169.89 - $231.37 $5.23 Million - $7.12 Million	-30,791 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$143.93 - $207.3 $4.43 Million - $6.38 Million	30,791 New	30,791 $5.19 Million
Q1 2019 May 14, 2019	SELL	$77.0 - $99.34 $2.11 Million - $2.73 Million	-27,441 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$83.85 - $110.34 $2.3 Million - $3.03 Million	27,441 New	27,441 $2.36 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.